Thus, the intriguing possibility that CB1R-mediated IRF5 signaling may contribute to skin and pulmonary fibrosis development in systemic sclerosis and scleroderma, needs to be explored in future studies. The gene discussed is CNR1; the disease is systemic sclerosis.